Biofeedback as an anti-craving tool for addiction

Biofeedback as an anti-craving tool for addiction - FeedFreeCraving

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00022483

Enrollment

140

Registered

2020-07-28

Start date

2022-04-25

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

other diagnoses of F1x.2 F10.2

Interventions

Group 1: Treatment as usual + Heart rate variability Biofeedback (over 2 weeks 3x/week, 20min each) Group 2: Treatment as usual

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: patients with addiction disease (F1x.2) treated on the ward 2062 (ward for comorbid addicts) and the addiction day clinic (2063) in the clinic in Ravensburg-Weissenau

Exclusion criteria

Exclusion criteria: no withdrawal medication, no medication with beta-blockers or methadone; no F2-disorder, no psychotic disorder, no F7-disorder; no language barrier

Design outcomes

Primary

Measure	Time frame
Experience of craving recorded via the Mannheim Craving Scale (MaSC) after training (post-measurement) and in follow-up (6, 12 months)	—

Secondary

Measure	Time frame
Abstinence rate (Ask for abstinence since end of training), asked after training (post-measurement) and in follow-up (6, 12 months)	—

Countries

Germany

Contacts

Public ContactPetra Schmid

ZfP Südwürttemberg - Versorgungsforschung Klinik I für Psychiatrie und Psychotherapie Universität Ulm

petra.schmid@zfp-zentrum.de0751-7601-2784

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026